Aplaviroc

Drug Profile

Aplaviroc

Alternative Names: 873140; AK 602; GW 873140; ONO-4128

Latest Information Update: 13 Mar 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ono Pharmaceutical
  • Developer GlaxoSmithKline
  • Class Antiretrovirals; Benzamides; Piperazines
  • Mechanism of Action CCR5 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 13 Mar 2006 Discontinued - Phase-III for HIV infections treatment in USA (PO)
  • 01 Feb 2006 Data presented at the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2005) have been added to the drug interactions and Viral infections pharmacodynamics trials sections
  • 13 Dec 2005 Data presented at the 10th European AIDS Conference (EACS-2005) have been added to the drug interactions and Viral infections antimicrobial activity sections ,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top